LUNG CANCER RESEARCH

Registered charity 1201017 · accounts filings on the Charity Commission register

The granting of funds for research into the cure of lung cancer

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£68k
Latest spending
£98k
Registered
2022
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that unrestricted reserves decreased from £366,020 to £335,866 during the year, resulting in a net movement in funds of negative £30,154. The charity reported incoming resources of £67,744, primarily from donations, against total resources expended of £97,898. The trustees confirmed that accounting records were kept in accordance with the Charities Act and no matters requiring attention were identified by the independent examiner.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Legacies (55% of income)
“Legacies from estates Christine Bellamy 37,507”
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Public fundraising profile: JustGiving — Lung Cancer Research (matched by registered charity number).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2024£68k£98k
31/12/2023£9k£115k

Common questions

Is LUNG CANCER RESEARCH financially healthy?

Per its FY2024 accounts: The accounts state that unrestricted reserves decreased from £366,020 to £335,866 during the year, resulting in a net movement in funds of negative £30,154. The charity reported incoming resources of £67,744, primarily from donations, against total resources expended of £97,898. The trustees confirmed that accounting records were kept in accordance with the Charities Act and no matters requiring attention were identified by the independent examiner. Its FY2024 accounts were independently examined.